## Abstract The aim of this study was to evaluate the efficacy and safety of bilateral pallidal (GPi) deep brain stimulation (DBS) 6 months after surgery in advanced parkinsonian patients whose dopa‐resistant axial motor signs or cognitive decline constituted contraindications for subthalamic nucle
Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson’s disease
✍ Scribed by V. G. H. Evidente; A. P. Premkumar; C. H. Adler; J. N. Caviness; E. Driver-Dunckley; M. K. Lyons
- Book ID
- 109339221
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 84 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0001-6314
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To compare body mass index (BMI) and daily energy intake (DEI) after subthalamic versus pallidal deep brain stimulation (DBS). Weight gain following DBS in Parkinson's disease patients remains largely unexplained and no comparison of subthalamic and pallidal (GPi) stimulation has yet be
FIG. 1. (A) Location of neuronal recording sites in a sagittal projection onto the Schaltenbrand Wahren atlas at the average laterality of 22 mm. (B) Mean firing rates in GPi and GPe are increased after STN-HFS. Box plots show median (line within the box) as well as 10, 25, 75, and 90th percentiles